Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Wolfe

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Contemporary Clinical Trials|December 20, 2022
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trialJulie H Levison, David Krane, Karen Donelan, et al.
BMC Public Health|June 26, 2024
Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trialStephen Bartels, Julie H Levison, Hao D Trieu, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Contemporary Clinical Trials|December 20, 2022
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trialJulie H Levison, David Krane, Karen Donelan, et al.
BMC Public Health|June 26, 2024
Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trialStephen Bartels, Julie H Levison, Hao D Trieu, et al.
Administration and Policy in Mental Health|November 8, 2023
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the PandemicVicki Fung, Julie H Levison, Anna Wilson, et al.
Disability and Health Journal|June 15, 2024
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilitiesJulie H Levison, Vicki Fung, Anna Wilson, et al.
Pageof 3